• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 9, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Two medications from Kazan University awarded at International Exhibition of Inventions

Bioengineer by Bioengineer
April 16, 2019
in Chemistry
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The event took place on April 10-14

The compounds are among the eight prospective medications developed by Kazan University’s Pharmaceutics Center.

Codename KFU-01 is a dipharmacophore, i. e. a framework of two active components which work in tandem after getting into the organism. The compound has shown significant advantages over all existing analogs in treating locomotor ailments.

Codename KFU-02 is a platform technology based on a reuptake inhibitor aimed at boosting the effectiveness of tumor treatment without chemotherapy.

Companies-residents of Skolkovo Innovation Center have been established to promote both medications. Russian and international patents have been registered. Clinical trials are expected to commence in Russia in 2019.

After evaluating over 70 exhibits in biomedicine, Geneva Exhibition committee gave both projects gold medals. They also received commendation from Russian Patent Service and national delegations of Taiwan and Iran.

According to KFU-01 and KFU-02 project leader, Director of Pharmaceutics Center Yury Shtyrlin, the medals mean that both medications have reached global awareness, which stimulates further intensive work.

###

Media Contact
Yury Nurmeev
[email protected]
https://kpfu.ru/eng/news-eng/geneva-exhibition-gold-medals.html

Tags: cancerMedicine/HealthOrthopedic MedicinePharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

Physical Neural Networks: Pioneering Sustainable AI for the Future

September 9, 2025
Record-Breaking Precision Attained for a Key Fundamental Physical Parameter

Record-Breaking Precision Attained for a Key Fundamental Physical Parameter

September 9, 2025

Breakthrough in Semiconductor Technology Sets New Efficiency Record for Broadband Satellite Communications

September 9, 2025

Flow-Driven Sensor Detects Amines in Water for Enhanced Pollution Monitoring

September 9, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    151 shares
    Share 60 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14
  • Physicists Develop Visible Time Crystal for the First Time

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracing the Origins of Wnt Signaling Uncovers a Protein Superfamily Spanning the Tree of Life

Revolutionary ‘On-Demand Blood’ Technology Promises to Transform Emergency Transfusions

Clinical Trial Indicates Pre-Surgery Immunotherapy as Promising Treatment for Rare Cancer

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.